Volume 74, Issue 4, Pages (October 2018)

Slides:

Advertisements

Similar presentations

Volume 53, Issue 3, Pages (March 2008)

Advertisements

Volume 55, Issue 1, Pages 1-8 (January 2009)

Volume 155, Issue 3, Pages (March 1996)

The PSA Era is not Over for Prostate Cancer

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Volume 66, Issue 1, Pages (July 2014)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Volume 191, Issue 6, Pages (June 2014)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 13, Issue 6, Pages (June 2012)

Volume 53, Issue 4, Pages (April 2008)

Volume 70, Issue 6, Pages (December 2016)

Prostate Cancer: Highlights from 2006

Claude C. Schulman, Jacques Irani, Juan Morote, Jack A

Volume 53, Issue 5, Pages (May 2008)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 65, Issue 5, Pages (May 2014)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 65, Issue 6, Pages (June 2014)

Volume 72, Issue 5, Pages (November 2017)

Volume 74, Issue 1, Pages (July 2018)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 62, Issue 1, Pages (July 2012)

Volume 68, Issue 3, Pages (September 2015)

Volume 56, Issue 2, Pages (August 2009)

Volume 70, Issue 4, Pages (October 2016)

Volume 67, Issue 6, Pages (June 2015)

Volume 71, Issue 5, Pages (May 2017)

Volume 64, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 53, Issue 2, Pages (February 2008)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Volume 71, Issue 1, Pages (January 2017)

Volume 68, Issue 6, Pages (December 2015)

Volume 53, Issue 6, Pages (June 2008)

Volume 74, Issue 2, Pages (August 2018)

Volume 53, Issue 4, Pages (April 2008)

Volume 66, Issue 2, Pages (August 2014)

Volume 58, Issue 1, Pages 1-7 (July 2010)

Volume 62, Issue 4, Pages (October 2012)

Volume 74, Issue 2, Pages (August 2018)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 50, Issue 5, Pages (November 2006)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Risk Factors for the Development of Bone Metastases in Prostate Cancer

Volume 55, Issue 6, Pages (June 2009)

Volume 13, Issue 6, Pages (June 2012)

Volume 71, Issue 5, Pages (May 2017)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance.

Volume 66, Issue 1, Pages (July 2014)

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Volume 74, Issue 6, Pages (December 2018)

Management of Prostate Cancer: Global Strategies

Volume 67, Issue 4, Pages (April 2015)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

European Urology Oncology

Volume 51, Issue 5, Pages (May 2007)

Volume 69, Issue 4, Pages (April 2016)

Presentation transcript:

Volume 74, Issue 4, Pages 422-429 (October 2018) A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer Stephanie Guillaumier, Max Peters, Manit Arya, Naveed Afzal, Susan Charman, Tim Dudderidge, Feargus Hosking-Jervis, Richard G. Hindley, Henry Lewi, Neil McCartan, Caroline M. Moore, Raj Nigam, Chris Ogden, Raj Persad, Karishma Shah, Jan van der Meulen, Jaspal Virdi, Mathias Winkler, Mark Emberton, Hashim U. Ahmed European Urology Volume 74, Issue 4, Pages 422-429 (October 2018) DOI: 10.1016/j.eururo.2018.06.006 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 Types of focal therapy using high-intensity focused ultrasound (HIFU) carried out in men with non-metastatic prostate cancer. European Urology 2018 74, 422-429DOI: (10.1016/j.eururo.2018.06.006) Copyright © 2018 The Authors Terms and Conditions

Fig. 2 Kaplan-Meier curves showing failure-free survival for (A) the entire group, (B) by D’Amico risk group, (C) by Gleason score, (D) by prostate-specific antigen (PSA) category, and (E) by T stage. European Urology 2018 74, 422-429DOI: (10.1016/j.eururo.2018.06.006) Copyright © 2018 The Authors Terms and Conditions